Abstract
In the Balsas region of North Brazil (85% prevalence of goiter), 1876 goitrous subjects (1663 with goiter grade I and II and 103 with grade III multinodular goiter) were treated with 1 ml of iodized oil im (l-oil). From the population with grade III goiter we were able to follow-up for 5 yr 13 euthyroid goitrous patients (group 1) and 8 goitrous individuals (group 2) who developed iodine-induced thyrotoxicosis (IIT, 0.42% of the total population or 7.76% of the multinodular goiter subjects). The two groups were matched for age and goiter size, and had no significant differences in the baseline levels of thyroid hormone concentration, T3/T4 ratio or mean serum TSH. However, group 2 had a higher concentration of serum Tg, and 48 h after challenge with 10 U of bovine TSH (bTSH) had a significantly higher absolute release of T3 and Tg than group 1. In 4 patients IIT was transitory and resolved by 12 months. Four other subjects, however, maintained a mild clinical form of IIT that only normalized at 50 months. Only one patient needed treatment with methylmercaptoimidazol. There was no evidence of autoantibodies (TSH-receptor inhibiting antibody, anti-Tg or anti-microsomal antibodies) against thyroid antigens in group 2 patients. All subjects, including those with thyrotoxicosis, showed a remarkable shrinkage of the goiter by 60 months which was reflected by a significantly lower absolute response of T3 and Tg after bTSH.(ABSTRACT TRUNCATED AT 250 WORDS)
MeSH Terms
Brazil
Follow-Up Studies
Goiter/complications,drug therapy,epidemiology
Humans
Iodine/adverse effects,therapeutic use
Thyroid Hormones/blood
Thyrotoxicosis/chemically induced
Thyrotropin/blood
Chemicals
Thyroid Hormones
Thyrotropin
Iodine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Martins M C
Division of Endocrinology, Hospital das Clinicas, University of Sao Paulo Medical School, Brazil.
Lima N
Knobel M
Medeiros-Neto G
References (15)
15 references, click to expand
-
Transient thyrotoxicosis in endemic goitre patients following exposure to a normal iodine intake.
Clin Endocrinol (Oxf). 1984 Dec;21(6):631-7
PMID: 6439440
-
Effect of potassium iodate on endemic goitre and protein-bound iodine levels in school-children.
Lancet. 1953 Jul 25;265(6778):166-8
PMID: 13070578
-
Iodide-induced thyrotoxicosis in Boston.
N Engl J Med. 1972 Sep 14;287(11):523-7
PMID: 5050425
-
[A form of genuine hyperthyroidism (Basedow's disease without exophthalmos) following ingestion of iodized bread].
Ned Tijdschr Geneeskd. 1954 Jan 9;98(2):81-9
PMID: 13144890
-
Long-term effect of iodized oil on serum thyroglobulin levels in endemic goitre patients.
Clin Endocrinol (Oxf). 1986 Jun;24(6):635-41
PMID: 3024868
-
Iodide-induced thyrotoxicosis.
Medicine (Baltimore). 1983 Jan;62(1):1-20
PMID: 6218369
-
Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
J Clin Endocrinol Metab. 1977 Jul;45(1):25-9
PMID: 577497
-
An improved radioreceptor assay for TSH receptor antibodies.
Clin Endocrinol (Oxf). 1982 Oct;17(4):409-17
PMID: 6291808
-
Endemic goitre in eastern New Guinea, with special reference to the use of iodized oil in prophylaxis and treatment.
Bull World Health Organ. 1967;36(2):243-62
PMID: 4294674
-
The changing age incidence of jodbasedow in Tasmania.
Med J Aust. 1973 Jul 28;2(4):171-4
PMID: 4741345
-
Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania.
J Clin Endocrinol Metab. 1973 Dec;37(6):901-9
PMID: 4753432
-
[Problems of hyperthyreosis during the introduction of endemic thyreopathic dystrophy prevention using iodine].
Vojnosanit Pregl. 1977 Nov-Dec;34(6):409-21
PMID: 611684
-
Self-limiting episodes of Jodbasedow.
Acta Endocrinol (Copenh). 1973 Nov;74(3):475-82
PMID: 4128227
-
Preclinical hyperthyroidism in multinodular goiter.
J Clin Endocrinol Metab. 1976 Oct;43(4):810-6
PMID: 61970
-
The effect of iodized oil on goitre size, thyroid function and the development of the Jod Basedow phenomenon.
Clin Endocrinol (Oxf). 1982 Sep;17(3):253-9
PMID: 6299619